MutaK., KrantzS.B., BondurantM.C., WickremaA.Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitorcells.J ClinInvest1994; 88: 34–43.
2.
KrantzS.B.Erythropoietin.Blood1991; 77: 419–34.
3.
EschbachJ.W., DowningM.R., EgrieJ.C., BrowneJ.K., AdamsonJ.W.USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.Contrib Nephrol1989; 76: 160–5.
4.
Van WyckD.B., StivelmanJ.C., RuizJ.Iron status in patients receiving erythropoietin for dialysis -associated anemia.Kidney Int1989; 35: 712–6.
5.
TarngD.C., ChenT.W., HuangT.P.Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.Am J Nephrol1995; 15: 230–7.
6.
Sunder-PlassmannG., HörlW.H.Importance of iron supply for erythropoietin therapy.Nephrol Dial Transplant1995; 10: 2070–6.
7.
UreñaP., EckardtK.U., SarfatiE.Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectormy.Nephron1991; 59: 384–93.
8.
WashioM., IsekiK., OnayomaK.Elevation of serum erythropoietin after subtotal parathyroidectomy in chronic hemodialysis patients.Nephrol Dial Trans plant1992; 7: 121–4.
9.
RaoD.S., ShihM.S., MohiniR.Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia.N Engl J Med1993; 328: 171–5.
10.
ZacheeP., VanuystelJ., DaelemansR., LinsR.L.Erythropoietin needs after parathyroidectomy in haemodialysis patients (Abstract).Nephrol Dial Transplant1994; 9: 1039.
11.
HernandezE., SanchezR., PragaM.Influence of intravenous calcitrol on the response to erythropoietin in haemodialysis patients with hyperparathyroidism (Abstract).Nephrol Dial Transplant1994; 9: 1031.
12.
DrüekeT.B.Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction.Neprhol Dial Transplant1993; 8(Suppl 1): 12–6.
13.
CannataJ.B., LopezJ.B.D.Insights into the complex aluminium and iron relationship.Nephrol Dial Transplant1991; 6: 605–7.
14.
BiaM.J., CooperK, SchnallS.Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.Kidney Int1989; 36: 852–8.
15.
DouglasS.W., AdamsonJ.W.The anemia of chronic disorders: studies of marrow regulation and iron metabolism.Blood1975; 45: 55–65.
16.
JohnsonR.A., CookC.A., FurmanskiP.In vivo suppression of erythropoiesis by tumor necrosis factor (TNF): reversal with exogenous erythropoietin.Exp Hematol1990; 18: 109–15.
17.
ClibonU., BonewaldL., CaroJ., RoodmanG.D.Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo.Exp Hematol1990; 18: 438–41.
18.
MacdougallI.C., AllenD.A., CavillI., BakerL.R.I., RaineA.E.G.Poor response to erythropoietin in inflammatory conditions may be mediated byinterleukin-6 (Abstract).Nephrol Dial Transplant1994; 9: 1033.
19.
BeguinY., LooM., R'ZikS.Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrinreceptor andfibrinogen.Blood1993; 82: 2010–16.
20.
RomeroR., NovoaD., Perez-FreiriaA.Responsiveness to erythropoietin and intrinsic inflammatory status in haemodialysis (Letter).NephrolDial Transplant1994; 9: 1696–7.
KamperA., NielsenO.Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.Scand J ClinLabInvest1990; 50: 611–8.
23.
DhontA.W., VanholderR.C., RingoirS.M.G.Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.Nephrol Dial Transplant1995; 10: 2107–9.
24.
WalterJ.Does captopril decrease the effect of recombinant erythropoietin in haemodialysis patients? (Abstract).Nephrol Dial Transplant1993; 8: 1428.
25.
IfuduO., FeldmanJ., FriedmanE.A.The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.N Engl J Med1996; 334: 420–5.
26.
NissensonA.R., KorbetS., FaberM., BurkartJ., GentileD.Multicenter trial of erythropoietin in patients on peritoneal dialysis.J Am Soc Nephrol1995; 5: 1517–29.
27.
ZacheeP., ChewS.L., DaelemansR., LinsR.L.Erythropoietin resistance due to vitamin B12 deficiency.Am J Nephrol1992; 12: 188–91.
28.
TomsonC.R.V., EdmundsM.E., ChambersK.Effects of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.Nephrol Dial Transplant1992; 7: 817–21.
29.
NgY.Y., ChowM.P., LyouJ.Y., HuH.Y.Resistance to erythropoietin: immunohemolytic anemia induced by residual formaldehyde in dialyzers.Am J Kidney Dis1993; 21: 213–6.
30.
LudwigH., FritzE., LeitgebC.Prediction of the response to erythropoietin treatment in chronic anemia of cancer.Blood1994; 84: 1056–63.
31.
SungurC., ArikN., YasavulU., TurganC., CaglarS.Decreased response to human recombinant erythropoietin therapy in pregnancy.Am J Nephrol1992; 12: 90.
